TWI239842B - Minoxidil-containing preparation - Google Patents
Minoxidil-containing preparation Download PDFInfo
- Publication number
- TWI239842B TWI239842B TW090108343A TW90108343A TWI239842B TW I239842 B TWI239842 B TW I239842B TW 090108343 A TW090108343 A TW 090108343A TW 90108343 A TW90108343 A TW 90108343A TW I239842 B TWI239842 B TW I239842B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- minoxidil
- patent application
- scope
- item
- Prior art date
Links
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 title claims abstract description 27
- 229960003632 minoxidil Drugs 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title description 4
- 239000000203 mixture Substances 0.000 claims abstract description 47
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims abstract description 12
- 238000004040 coloring Methods 0.000 claims abstract description 12
- -1 butylhydroxyl Chemical group 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 4
- 229920001223 polyethylene glycol Polymers 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 claims 1
- XLMQKIPKERJVHK-UHFFFAOYSA-N 1-(2-methoxyphenyl)butan-1-one Chemical group CCCC(=O)C1=CC=CC=C1OC XLMQKIPKERJVHK-UHFFFAOYSA-N 0.000 claims 1
- 241001024304 Mino Species 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 abstract description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 abstract description 2
- 235000010350 erythorbic acid Nutrition 0.000 abstract description 2
- 239000004318 erythorbic acid Substances 0.000 abstract description 2
- 229940026239 isoascorbic acid Drugs 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 14
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000000839 emulsion Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000002079 cooperative effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ASJCVVGLGXVRGQ-UHFFFAOYSA-N 1-butyl-2-methoxybenzene Chemical compound CCCCC1=CC=CC=C1OC ASJCVVGLGXVRGQ-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000511010 Eustoma Species 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000147041 Guaiacum officinale Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- YYVFXSYQSOZCOQ-UHFFFAOYSA-N Oxyquinoline sulfate Chemical compound [O-]S([O-])(=O)=O.C1=C[NH+]=C2C(O)=CC=CC2=C1.C1=C[NH+]=C2C(O)=CC=CC2=C1 YYVFXSYQSOZCOQ-UHFFFAOYSA-N 0.000 description 1
- 241000736199 Paeonia Species 0.000 description 1
- 244000236658 Paeonia lactiflora Species 0.000 description 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000010227 chenpi Substances 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000006103 coloring component Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- VZFDRQUWHOVFCA-UHFFFAOYSA-L disodium;2-sulfanylbutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(S)C([O-])=O VZFDRQUWHOVFCA-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940091561 guaiac Drugs 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000006178 methyl benzyl group Chemical group 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Description
A7 經濟部智慧財產局員工消費合作社印製 1239842 B7 五、發明説明(彳) 本發明係關於防止經時著色之含有米諾地爾的組成物 【先行技術】 米諾地爾因爲其育毛效果,而被期待爲外用育毛劑之 成份。 惟,於溶液狀態下保存的米諾地爾,因容易有經時著 色之缺點,可能造成商品價値低下。 【發明所欲解決之課題】 本發明係防止配合米諾地爾之組成物著色爲目的。 【用以解決課題之手段】 一般,配合容易著色成份的液劑時,被考量配合二丁 基羥基甲苯等抗氧化劑使其改善。本發明者發現含有米諾 地爾之液劑中配合二丁基羥基甲苯等抗氧化劑也幾乎無法 防止著色,或者不但沒有防止著色反而使之增強一事。 於此,爲解決此問題而經精密硏究結果,藉由調整含 有米諾地爾之液劑組成物的p Η爲5 . 5〜7 . 0時,發 現不但改善上述之不利點,並能使液劑著色防止/效果顯著 向上,進而完成本發明。 亦即,本發明爲配合抗氧化劑且ρ Η爲5 . 5〜 7 · 0之含有米諾地爾的組成物。 又,本發明爲配合二丁基羥基甲苯或丁羥基苯甲醚 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐)~' — ' -4 - (請先閱讀背面之注意事項再填寫本頁)
經濟部智慧財產局員工消費合作社印製 1239842 A7 _ B7 五、發明説明(2 ) pH爲5 · 5〜7 · 0之含有米諾地爾的組成物。 又,本發明爲於含有米諾地爾的組成物中,配合抗氧 化劑,且P Η爲5 · 5〜7 · 〇爲特徵之組成物的著色防 止方法。 【發明之實施之形態】 於本發明中使用的抗氧化劑係由,二丁基羥基甲苯, 丁羥基苯甲醚,異抗壞血酸,EDTA—2Na ,檸檬酸 異丙酚,沒食子酸丙酯,愈瘡木酸,α -硫甘油,二氯化 異氰尿酸鉀,2 ’ 6 —二第三丁基—4 一甲酚,大豆卵磷 脂,氫硫基乙酸鈉,硫代蘋果酸鈉,軟脂酸抗壞血酸脂, 2 -氫硫基苯并咪唑,羥基喹啉硫酸鹽,所成群當中選出 一種或二種爲理想。又,抗氧化劑也可使用生藥萃取物, 特別是丁香,老鸛草,大黃,黃柏,芍藥,牡丹皮,黃連 ,陳皮,蛇麻草,黃芩,桂皮,甘草,桔梗,生薑,紅花 ,當歸的萃取物,所成物當中選出一種或二種爲理想。這 些生藥萃取物可由水,碳素數2〜4的乙醇(例如:乙醇 ,丙二醇,1 ,3 — 丁二醇,甘油等)或者是其混合溶媒 爲抽出溶媒使用時取得。 本組成物中之抗氧化劑的配合量以米諾地爾1質量部 對0 · 0 0 5〜0 · 5質量部爲理想,而更理想者爲 〇 · 0 1〜0 · 5質量部。因抗氧化劑的種類而有所不同 ,但沒有添加足夠的量時,就算Ρ Η在5 . 5〜Τ7 . 0的 範圍內也會使著色增強。 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) (請先閱讀背面之注意事項再填寫本頁)
-5- 1239842 A7 B7 五、發明説明(3 ) ^ 本發明的組成物由p Η越低著色防止效果越小一事, Ρ Η在5 · 5以上爲理想,而更理想者爲5 · 7以上。 (請先閱讀背面之注意事項再填寫本頁) 又’由米諾地爾的溶解性之點,ρ Η在7 · 0以下爲 理想,而更理想者爲6 · 3以下。 於本發明的組成物之ρ Η調整可用通常被使用之ρ Η 調整劑,具體而言,例如:檸檬酸,蘋果酸,乳酸等有機 酸,和磷酸,鹽酸,硫酸等無機酸可被列舉出。 本發明的組成物之米諾地爾的濃度以組成物全體的1 〜1 0質量%爲理想, 更理想者爲3〜6質量%。 本發明的組成物以配合多價乙醇或聚乙二醇爲溶媒者 較理想。 多價乙醇以丙二醇,一縮二丙二醇,1 ,3 — 丁二醇 ,甘油,己二醇,聚乙二醇爲理想,而更理想者爲1 ,3 —丁二醇。聚乙二醇以 Macrogoul 2 0 0 及 Macrogoul 4 0 0爲理想。多價乙醇的配合量以米諾地爾1質量部對1〜 5〇質量部爲理想。 經濟部智慧財產局員工消費合作社印製 本發明的組成物之形態,並無特別限定,舉凡乳液劑 ,氣溶膠劑,凝膠劑等任何一種皆可,.其製造方法可由醫 藥品或化妝用料之製劑化的一般方法調製而成。 又,本發明的組成物可應需要,配合溶解補助劑(脂 肪酸酯,多價乙醇脂肪酸酯,中鏈脂肪酸甘油酯,植物油 ,烷基甘油醚),界面活性劑(非離子性界面活性劑,卵 磷脂誘導體,高分子乳化劑)’乳化安定劑,吸收促進劑 本紙張尺度適用中國國家標準(CNS ) A4規格(210Χ297公釐) - ' -6 - 1239842 Α7 Α7 Β7 五、發明説明(4 ) 等。 【發明之效果】 根據本發明,可能提供長期防止著色之含有米諾地爾 的組成物。 實施例 以下,藉由實施例以及試驗例進行本發明更詳細之說 明。又,pH爲使用由玻璃電極之PH計(東亞電波工業 製),針對製劑5 in L測定5分鐘後之ρ Η。 實施例1 於米諾地爾5g ,1 ,3 — 丁二醇30g ,乙醇5〇 g,二丁基羥基甲苯0 · 5g中添加磷酸〇 · 5mL,用 精製水使其總量爲1 〇 〇 m L,攪拌溶解調製成乳液狀的 組成物。組成物的P Η爲6 ·〇。 實施例2 於米諾地爾5 g,1 ,3 - 丁二醇3 〇 g ,乙醇5 0 g,二丁基羥基甲苯0 · lg中添加磷酸〇 · 9mL,用 精製水使其總量爲1 0 0 m L· ’攪拌溶解調製成乳液狀的 組成物◦組成物的P Η爲5 · 5。 實施例3 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公嫠) (請先閱讀背面之注意事項再填寫本頁) 訂 %· 經濟部智慧財產局員工消費合作社印製 A7 1239842 B7 五、發明説明(5 ) 於米諾地爾,1 ,3 一丁一醇3〇g ,乙醇5〇 (請先閱讀背面之注意事項再填寫本頁) g,二丁其声基甲笨0 · 5g中添加檸檬酸〇 · 55g , 用精製水使其總纛爲1 0 0 m L ’擾拌溶解調製成乳液狀 的組成物。組成物的p Η爲6 · 4。 實施例4 於米諾地爾32 ,1 ,3 — 丁一醇30g ,乙醇5〇 g ,丁羥基苯甲醚0 · 5g中添加碟酸0 · 02mL ’用 精製水使其總量爲1 0 0 m L ’攪拌溶解調製成乳液狀的 組成物。組成物的P H爲7 · 0 ° 實施例5 於米諾地爾5S ’丙二醇52S ’乙醇25§ ’二丁 基羥基甲苯0 . 5S ’添加磷酸〇 · 3mL ’用精製水使 其總量爲1 0 0 m L ’ « 容角f胃_ $ 1 '液H犬0勺$且/¾ % ° 組成物的P Η爲6. · 〇 ° 經濟部智慧財產局員工消費合作社印製 比較例1 於米諾地爾3 g ’ 1 ’ 3 — 丁二醇3 0 g ,乙醇5 〇 g,二丁基羥基甲苯〇 · 5g中添加.精製水’使其總量爲 1 〇 〇 m L,攪拌溶解調製成乳液狀的組成物。組成物的 p Η 爲 8 · 8。 比較例2 _________________— 本紙張尺度適用中國國家標準(CNS) Α4規格(210x297公釐) 1239842 A7 __B7____ 五、發明説明(6 ) 添加米諾地爾5g ,丙二醇52g ’乙醇25g ’用 (請先閱讀背面之注意事項再填寫本頁) 精製水使其總量爲1 0 0 m L,攪拌溶解調製成乳液狀的 組成物。組成物的P Η爲8 · 7。 比較例3 於米諾地爾5 g,丙二醇5 2 g ,乙醇2 5 g ’添加 磷酸〇 · 〇 3 m L,用精製水使其總纛爲1 0 0 m L ’擾 拌溶解調製成乳液狀的組成物。組成物的P H爲6 · 0 ° 比較例4 於米諾地爾5 g,丙二醇5 2 g,乙醇2 5 g ’添加 二丁基羥基甲苯〇 · 5 g,用精製水使其總量爲1 0 0 m L,攪拌溶解調製成乳液狀的組成物。組成物的p H爲 8.7° 試驗例1 經濟部智慧財產局員工消費合作社印製 將實施例1〜4,比較例1的組成物個別塡充於保特 瓶容器內,保存於5 0 °C下1個月,進行外觀(色調)之 觀察。 外觀的評價,係根據以下基準進行。 0 :不被斷定著色,成爲商品並無問題。 1 :雖有些許著色,但成爲商品並無問題。 2 :著色被斷定,成爲商品有問題。 其結果如表1所示。 ^紙張尺度適用中國國家K( CNS ) A4規格(210X297公釐) ' ^ -9- 1239842 A7 B7 五、發明説明(7 表1 製劑例 實施例1 實施例2 1——--- 3 實施例4 比較例1 —PH 6 5.5 7 8.8 評價 0 1 1 2 經濟部智慧財產局員工消費合作社印製 比較例1中因著色被斷定而被判斷於商品性上有問題 ,於實施例1〜4的組成物不被斷定著色,或有些許著色 也被判斷成爲商品並無問題。 試驗例2 實施例5,將比較例2〜4的組成物個別塡充於保特 瓶容器內,保存於5 0 °C下1個月者以吸光高度計( B a c k m a η公司製)測定其吸光度(4 2 0 n m )。 其結果如表2所示。 表2 製劑例 實施例5 比較例2 比較例3 比較例4 pH 6 8.7 6 8.7 Β Η T 〇.5g 〇g 〇g 0.5g 吸光度(420nm) 0.013 0.021 0.058 0.039 由比較例2以及比較例3的結果顯示,使米諾地爾組 成物P Η低下時更會加強其著色。又,由比較例4的結果 得知添加Β Η Τ不但沒有防止著色反而會使著色增強一事 本紙張尺度適用中國國家標準(CNS ) Α4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁)
1239842 A7 B7 五、發明説明(8 ) 防 色 著 的 佳 例 較 比 之 何 任 比 到 得 中 5 例 施 實 於 此。 對果 效 止 (請先閱讀背面之注意事項再填寫本頁) 、訂 經濟部智慧財產局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) -11 -
申請曰期 90 年 4 月 6 日 案 號 90108343 類 別 (以上各攔由本局填註)AW 1239842中文說明書替換頁 民國94年1月5曰呈 α Α4 ]C4 驀4專利説明書 中 文 含有米諾地爾(Mi nox i d i 1)之製劑 發明 新型 名稱 英 文
MinoxidiI-containing preparation
I 名 姓 國 籍 二美子 康留孝 村合ig 今落岡a)ss (1)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 裝 發明 創作 人 住、居所 (2)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 (3)日本國東京都豊島區高田三丁目二四番一號大正製薬株式会 社内 訂 姓 名 (名稱) (1)大正製藥股份有限公司 大正製蘂株式会社 線 經濟部智慧財產局員、工消費合作社印製 國 籍 住、居所 (事務所) 代表人 姓 名 (1)日本 (1)日本國東京都豊島區高田三丁目二四番一號 ⑴上原明 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)
Claims (1)
- 8 8 8 8 ABCD 1239842 六、申請專利範圍 r-一·—一一 一了一一| 第90 1 08343號專利申請案 ! :..> -'--S i年n ’二'::·〉: j 中文申請專利範圍修正本 -' 民國94年1月5日修正 1 . 一種用於改善著色之組合物,其特徵爲配合1種或 2種選自二丁基羥基甲苯及丁羥基苯甲醚所成群’米諾地爾 的濃度爲3〜6質量%,pH爲5 · 5〜7 · 〇 ° 2 .如申請專利範圍第1項之組合物’其中P H爲 5 · 7 〜6 . 3。 3 .如申請專利範圍第1項或第2項之組合物’其中配 合1種或2種選自二丁基羥基甲苯及丁經基苯甲醚所成群’ 對1質量份的而言爲米諾地爾1質量部對0 · 0 0 5〜 0 . 5質量份者。 4 .如申請專利範圍第1項或第2項之組合物’其中更 配合多元醇者。 5 .如申請專利範圍第1項至第4項中任一項之組合物 ,其中更配合聚乙二醇者。 6 . —種用於改善著色之方法,其特徵爲於含有米諾地 爾的組成物中,配合1種或2種選自二丁基經基甲苯及了* ^ 基苯甲醚所成群,且pH爲5 . 5〜7 _ 〇者。 本紙張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁:> -裝* 訂 經濟部智慧財產局員工消費合作社印製
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000107028A JP4780429B2 (ja) | 2000-04-07 | 2000-04-07 | ミノキシジル含有製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI239842B true TWI239842B (en) | 2005-09-21 |
Family
ID=18620086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW090108343A TWI239842B (en) | 2000-04-07 | 2001-04-06 | Minoxidil-containing preparation |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1273299B1 (zh) |
| JP (1) | JP4780429B2 (zh) |
| KR (1) | KR100740393B1 (zh) |
| CN (1) | CN1279914C (zh) |
| AT (1) | ATE306925T1 (zh) |
| AU (1) | AU778783B2 (zh) |
| BR (1) | BR0109847A (zh) |
| CA (1) | CA2405429C (zh) |
| DE (1) | DE60114171T2 (zh) |
| DK (1) | DK1273299T3 (zh) |
| ES (1) | ES2250374T3 (zh) |
| HU (1) | HUP0301124A2 (zh) |
| NZ (1) | NZ521733A (zh) |
| RU (1) | RU2275914C2 (zh) |
| TW (1) | TWI239842B (zh) |
| WO (1) | WO2001076605A1 (zh) |
| ZA (1) | ZA200207960B (zh) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
| AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
| JP5785353B2 (ja) * | 2004-02-27 | 2015-09-30 | 大正製薬株式会社 | 眼科用剤 |
| TW200534875A (en) * | 2004-04-23 | 2005-11-01 | Lonza Ag | Personal care compositions and concentrates for making the same |
| JP2006022091A (ja) * | 2004-06-09 | 2006-01-26 | Dai Ichi Seiyaku Co Ltd | 育毛用組成物 |
| JP5040060B2 (ja) * | 2004-10-14 | 2012-10-03 | 大正製薬株式会社 | メチオニン配合内服液剤 |
| CN101610751B (zh) * | 2006-12-20 | 2012-03-21 | 大正制药株式会社 | 脱发症的预防或治疗剂 |
| US20090175810A1 (en) | 2008-01-03 | 2009-07-09 | Gareth Winckle | Compositions and methods for treating diseases of the nail |
| JP5286999B2 (ja) * | 2008-07-10 | 2013-09-11 | 大正製薬株式会社 | ミノキシジル含有液剤 |
| MX2011003207A (es) | 2008-09-27 | 2011-11-04 | Jina Pharmaceuticals Inc | Preparaciones farmaceuticas a base de lipidos para la aplicacion oral y topica; sus composiciones, metodos y usos. |
| US8470833B2 (en) * | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Hair growth and/or regrowth compositions |
| US8039494B1 (en) | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| JP6067036B2 (ja) * | 2013-01-31 | 2017-01-25 | 富士フイルム株式会社 | 乳化組成物 |
| JP6199066B2 (ja) * | 2013-04-24 | 2017-09-20 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
| KR101580119B1 (ko) * | 2013-04-29 | 2015-12-29 | 한국유나이티드제약 주식회사 | 쓴맛이 차폐된 황련 추출물을 포함하는 경구투여용 제제 |
| US9662394B2 (en) * | 2013-10-03 | 2017-05-30 | Dow Pharmaceutical Sciences, Inc. | Stabilized efinaconazole compositions |
| CN112999223A (zh) | 2013-11-22 | 2021-06-22 | 博世健康爱尔兰有限公司 | 抗感染的方法、组合物和装置 |
| JP6736889B2 (ja) * | 2015-01-23 | 2020-08-05 | 大正製薬株式会社 | 外用組成物 |
| JP6052686B2 (ja) * | 2015-02-06 | 2016-12-27 | ダイヤ製薬株式会社 | 外用液剤 |
| JP6528194B2 (ja) * | 2015-02-06 | 2019-06-12 | ダイヤ製薬株式会社 | ミノキシジル含有外用液剤および外用液剤の製造方法 |
| JP6825354B2 (ja) * | 2015-12-29 | 2021-02-03 | 大正製薬株式会社 | 外用組成物 |
| JP7346010B2 (ja) * | 2016-09-15 | 2023-09-19 | 大正製薬株式会社 | 外用組成物 |
| KR102000217B1 (ko) * | 2017-08-08 | 2019-07-15 | 에스씨엠생명과학 주식회사 | Cxcl1 단백질 및 미녹시딜을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
| JP2017206558A (ja) * | 2017-08-22 | 2017-11-24 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
| JP2020023467A (ja) * | 2018-01-19 | 2020-02-13 | ロート製薬株式会社 | 外用製剤、液切れ性を改善する方法、および、液切れ性改善剤 |
| JP7304463B2 (ja) * | 2018-01-29 | 2023-07-06 | 富士化学工業株式会社 | ミノキシジル含有外用組成物 |
| JP2019014764A (ja) * | 2018-11-06 | 2019-01-31 | ロート製薬株式会社 | ミノキシジル含有外用組成物 |
| JP7488634B2 (ja) * | 2019-07-10 | 2024-05-22 | ロート製薬株式会社 | 外用製剤 |
| JP7575722B2 (ja) * | 2019-10-28 | 2024-10-30 | 大正製薬株式会社 | 外用医薬組成物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601359B1 (fr) * | 1986-07-09 | 1988-10-28 | Cird | Nouveaux derives bicycliques naphtaleniques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique. |
| FR2621912B1 (fr) * | 1987-10-16 | 1990-03-02 | Oreal | Nouveaux derives du norbornane, leur procede de preparation et compositions cosmetique et medicamenteuse les contenant |
| EP0327263B1 (en) * | 1988-01-29 | 1994-09-07 | PROCTOR, Peter H. | Hair growth stimulation with nitroxide and other radicals |
| FR2641184B1 (fr) * | 1988-12-30 | 1991-04-05 | Oreal | Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute, a base de derives de pyrimidine et de filtres solaires |
| JP2511714B2 (ja) * | 1989-12-05 | 1996-07-03 | 一丸ファルコス株式会社 | 植物由来抽出成分からなるフケ菌発育阻害剤を含有する皮膚・頭皮・頭髪用化粧料 |
| AU697389B2 (en) * | 1992-09-14 | 1998-10-01 | Walter P. Smith | Skin-conditioning composition its application and manufacture |
| JP4467085B2 (ja) * | 1996-01-05 | 2010-05-26 | 大正製薬株式会社 | ヒノキチオール含有組成物 |
| FR2756561B1 (fr) * | 1996-12-04 | 1999-01-08 | Cird Galderma | Composes heteroaryles, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
| JPH11349451A (ja) * | 1998-06-08 | 1999-12-21 | Taisho Pharmaceut Co Ltd | 育毛剤 |
-
2000
- 2000-04-07 JP JP2000107028A patent/JP4780429B2/ja not_active Expired - Lifetime
-
2001
- 2001-04-05 DE DE60114171T patent/DE60114171T2/de not_active Expired - Fee Related
- 2001-04-05 WO PCT/JP2001/002951 patent/WO2001076605A1/ja not_active Ceased
- 2001-04-05 CN CNB018106498A patent/CN1279914C/zh not_active Expired - Fee Related
- 2001-04-05 BR BR0109847-0A patent/BR0109847A/pt not_active Application Discontinuation
- 2001-04-05 CA CA002405429A patent/CA2405429C/en not_active Expired - Fee Related
- 2001-04-05 AT AT01919789T patent/ATE306925T1/de not_active IP Right Cessation
- 2001-04-05 HU HU0301124A patent/HUP0301124A2/hu unknown
- 2001-04-05 NZ NZ521733A patent/NZ521733A/en unknown
- 2001-04-05 DK DK01919789T patent/DK1273299T3/da active
- 2001-04-05 RU RU2002126553/15A patent/RU2275914C2/ru active
- 2001-04-05 EP EP01919789A patent/EP1273299B1/en not_active Expired - Lifetime
- 2001-04-05 KR KR1020027013331A patent/KR100740393B1/ko not_active Expired - Fee Related
- 2001-04-05 ES ES01919789T patent/ES2250374T3/es not_active Expired - Lifetime
- 2001-04-05 AU AU46839/01A patent/AU778783B2/en not_active Ceased
- 2001-04-06 TW TW090108343A patent/TWI239842B/zh not_active IP Right Cessation
-
2002
- 2002-10-03 ZA ZA200207960A patent/ZA200207960B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2405429A1 (en) | 2001-10-18 |
| DK1273299T3 (da) | 2006-02-06 |
| ES2250374T3 (es) | 2006-04-16 |
| EP1273299A1 (en) | 2003-01-08 |
| HK1056510A1 (zh) | 2004-02-20 |
| BR0109847A (pt) | 2003-06-24 |
| EP1273299A4 (en) | 2003-05-14 |
| ZA200207960B (en) | 2004-01-27 |
| RU2002126553A (ru) | 2004-03-20 |
| KR100740393B1 (ko) | 2007-07-16 |
| CN1279914C (zh) | 2006-10-18 |
| JP2001288090A (ja) | 2001-10-16 |
| JP4780429B2 (ja) | 2011-09-28 |
| KR20020087126A (ko) | 2002-11-21 |
| HUP0301124A2 (hu) | 2003-08-28 |
| DE60114171T2 (de) | 2006-07-06 |
| CA2405429C (en) | 2007-09-04 |
| CN1431903A (zh) | 2003-07-23 |
| AU778783B2 (en) | 2004-12-23 |
| EP1273299B1 (en) | 2005-10-19 |
| ATE306925T1 (de) | 2005-11-15 |
| NZ521733A (en) | 2003-08-29 |
| WO2001076605A1 (en) | 2001-10-18 |
| DE60114171D1 (de) | 2006-03-02 |
| AU4683901A (en) | 2001-10-23 |
| RU2275914C2 (ru) | 2006-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI239842B (en) | Minoxidil-containing preparation | |
| TWI289459B (en) | Hair growth stimulant compositions | |
| TW508245B (en) | Stable topical cosmetic/pharmaceutical emulsion compositions containing ascorbic acid | |
| TWI285551B (en) | Minocycline-containing compositions | |
| TWI240635B (en) | Active vitamin D3 emulsion lotion | |
| TWI285114B (en) | Hair growth stimulant compositions with sustained action | |
| Hosny et al. | Oral gel loaded with penciclovir–lavender oil nanoemulsion to enhance bioavailability and alleviate pain associated with herpes labialis | |
| TW440449B (en) | A mixture composition of oils and water without surfactant | |
| JPH11193208A (ja) | 香料可溶化組成物及びこれを配合した外用組成物 | |
| JP4796260B2 (ja) | ミノキシジル含有製剤 | |
| JPH10245315A (ja) | シクロジペプタイド誘導体を含有する組成物 | |
| CN114404325A (zh) | 一种可无限稀释水包油型菜籽油微乳液及其制备方法和应用 | |
| JPH0532521A (ja) | ゲル状化粧料 | |
| JPH0536412B2 (zh) | ||
| JP6880871B2 (ja) | エアゾール剤 | |
| JP4872153B2 (ja) | 液体組成物 | |
| TWI232758B (en) | High concentration vitamin C composition and method for preparing the same | |
| JP7449692B2 (ja) | 油性外用組成物 | |
| CN110799169A (zh) | 化妆品 | |
| KR102390748B1 (ko) | 디클로페낙 함유 유화 겔 조성물 | |
| JP2004196709A (ja) | ゲル状組成物、芳香剤、皮膚外用剤及び化粧料 | |
| JP2009091341A (ja) | エアゾール剤 | |
| JP6848565B2 (ja) | エアゾール剤 | |
| JP4992181B2 (ja) | 外用剤組成物 | |
| BRPI0617258A2 (pt) | soluções aquosas escoáveis altamente concentradas de ibuprofeno de potássio suas preparações e seus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |